Case Studies

Compass Executives supported Novo Nordisk – a global leader in producing treatments for diabetes and other serious chronic diseases including rare blood, and rare endocrine diseases – to secure a LEAN Partner following several failed attempts through direct and local searches.

Following a period of neglect at the Kalundborg factory site, employing more than 2,500 staff, a LEAN Partner was required to reintroduce LEAN methods of working, which would subsequently be rolled out across other sites – requiring an experienced executive search firm to support this critical hire following several failed internal attempts.

Amplo Biotechnology is a newly formed Adeno-Associated Virus (AAV) company for congenital myasthenia syndrome (CMS) and general myasthenia. Compass Executives have recently appointed a CMO to begin critical work on Amplo’s first preclinical project (AAV9-DOK7).

Owing to Compass Executives’ Life Sciences Practice’s outstanding network, the team were able to introduce an interim CMO whilst a concurrent process was being run in the background to source a full time Chief Medical Officer.

Compass Executives were mandated by the largest publicly listed and most innovative Biopharma, Hengrui Therapeutics, to source a Vice President, Head of European Research Centre, Biologic Drug Discovery for the business. With more than 30,000 employees globally, including in excess of 3,200 scientists worldwide, Hengrui Therapeutics hosts the discovery R&D units focusssing on protein engineering on new mRNA technology platforms, and have a pipeline of 30 global programmes in clinical development across oncology, anaesthesiology pain management, autoimmunity, and CVMD’s.

Given the complexity of the role a highly respected candidate was required with entrepreneurial and hands-on expertise to proactively establish a new laboratory from scratch and build out a new team (20-30 scientists), to be based in Zurich.